Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
Authors:
- 1 October 2009
- journal article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 13 (5) , 438-446
Abstract
Proteinuria caused by glomerular disease is characterized by podocyte injury. Vasopressin V2 receptor antagonists are effective in reducing albuminuria, although their actions on glomerular podocytes have not been explored. The objective of this study was to evaluate the effects of tolvaptan, a selective oral V2 receptor antagonist, on podocytes in a puromycin aminonucleoside (PAN)-induced nephrosis rat model. Rats were allocated to a control, PAN nephrosis, or tolvaptan-treated PAN nephrosis group (n = 9 per group). Urinary protein excretion and serum levels of total protein, albumin, creatinine, and total cholesterol were measured on day 10. The influence of tolvaptan on podocytes was examined in renal tissues by immunofluorescence and electron microscopy. PAN induced massive proteinuria and serum creatinine elevation on day 10, both of which were significantly ameliorated by tolvaptan. Immunofluorescence studies of the podocyte-associated proteins nephrin and podocin revealed granular staining patterns in PAN nephrosis rats. In tolvaptan-treated rats, nephrin and podocin expressions retained their normal linear pattern. Electron microscopy showed foot process effacement was ameliorated in tolvaptan-treated rats. Tolvaptan is protective against podocyte damage and proteinuria in PAN nephrosis. This study indicates that tolvaptan exerts a renoprotective effect by affecting podocyte morphology and probably function in PAN nephrosis. Tolvaptan is a promising pharmacological tool in the treatment of renal edema.Keywords
This publication has 27 references indexed in Scilit:
- Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetesJournal of Clinical Investigation, 2006
- Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathyKidney International, 2005
- Cloning of rat nephrin: Expression in developing glomeruli and in proteinuric statesKidney International, 2000
- Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrinJournal of Clinical Investigation, 1999
- Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.Journal of Clinical Investigation, 1995
- Adaptation of the kidney to protein intake and to urine concentrating activity: Similar consequences in health and CRFKidney International, 1995
- Arginine vasopressin gene expression in rats with puromycin-induced nephrotic syndromeAmerican Journal of Kidney Diseases, 1995
- Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction.Journal of Clinical Investigation, 1993
- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.Journal of Clinical Investigation, 1986
- Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the ratKidney International, 1981